News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
756,029 Results
Type
Article (45550)
Company Profile (332)
Press Release (710131)
Multimedia
Podcasts (120)
Webinars (22)
Section
Business (212566)
Career Advice (2117)
Deals (36557)
Drug Delivery (129)
Drug Development (82773)
Employer Resources (177)
FDA (17043)
Job Trends (15435)
News (357807)
Policy (33645)
Tag
2027 BioCapital Elite (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2742)
Accelerated approval (42)
Adcomms (25)
Allergies (165)
Alliances (52644)
ALS (195)
Alzheimer's disease (1769)
Antibody-drug conjugate (ADC) (381)
Approvals (17353)
Artificial intelligence (645)
Autoimmune disease (228)
Automation (52)
Bankruptcy (367)
Best Places to Work (11934)
BIOSECURE Act (20)
Biosimilars (206)
Biotechnology (221)
Bladder cancer (179)
Brain cancer (64)
Breast cancer (695)
Cancer (5385)
Cardiovascular disease (450)
Career advice (1797)
Career pathing (40)
CAR-T (312)
CDC (55)
Celiac Disease (2)
Cell therapy (832)
Cervical cancer (41)
Clinical research (71113)
Collaboration (1979)
Company closure (5)
Compensation (1281)
Complete response letters (70)
COVID-19 (2812)
CRISPR (106)
C-suite (1010)
Cystic fibrosis (154)
Data (7115)
Decentralized trials (3)
Denatured (44)
Depression (155)
Dermatology (58)
Diabetes (554)
Diagnostics (7111)
Digital health (54)
Diversity (13)
Diversity, equity & inclusion (45)
Drug discovery (310)
Drug pricing (196)
Drug shortages (31)
Duchenne muscular dystrophy (272)
Earnings (92803)
Editorial (61)
Employer branding (22)
Employer resources (157)
Events (123316)
Executive appointments (1069)
FDA (20525)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (29)
Funding (1670)
Gene editing (226)
Generative AI (58)
Gene therapy (687)
GLP-1 (1036)
Government (4801)
Grass and pollen (7)
Guidances (398)
Healthcare (19649)
HIV (77)
Huntington's disease (52)
IgA nephropathy (91)
Immunology and inflammation (276)
Immuno-oncology (82)
Indications (158)
Infectious disease (3132)
Inflammatory bowel disease (207)
Inflation Reduction Act (14)
Influenza (132)
Intellectual property (281)
Interviews (328)
IPO (16998)
IRA (51)
Job creations (3835)
Job search strategy (1501)
JPM (62)
Kidney cancer (18)
Labor market (93)
Layoffs (569)
Leadership (36)
Legal (8178)
Liver cancer (100)
Longevity (28)
Lung cancer (717)
Lymphoma (409)
Machine learning (54)
Management (63)
Manufacturing (942)
MASH (177)
Medical device (14605)
Medtech (14686)
Mergers & acquisitions (20730)
Metabolic disorders (1423)
mRNA (195)
Multiple sclerosis (172)
NASH (17)
Neurodegenerative disease (390)
Neuropsychiatric disorders (97)
Neuroscience (3179)
Neurotech (1)
NextGen: Class of 2026 (6860)
Non-profit (4665)
Now hiring (73)
Obesity (667)
Opinion (289)
Ovarian cancer (186)
Pain (231)
Pancreatic cancer (258)
Parkinson's disease (343)
Partnered (34)
Patents (568)
Patient recruitment (603)
Peanut (63)
People (61557)
Pharmaceutical (68)
Pharmacy benefit managers (32)
Phase 1 (22326)
Phase 2 (31281)
Phase 3 (23212)
Pipeline (7189)
Policy (312)
Postmarket research (2584)
Preclinical (9547)
Press Release (71)
Prostate cancer (278)
Psychedelics (49)
Radiopharmaceuticals (323)
Rare diseases (1006)
Real estate (6292)
Recruiting (70)
Regulatory (25618)
Reports (54)
Research institute (2547)
Resumes & cover letters (365)
Rett syndrome (32)
RNA editing (20)
RSV (86)
Schizophrenia (166)
Series A (281)
Series B (203)
Service/supplier (14)
Sickle cell disease (108)
Special edition (22)
Spinal muscular atrophy (165)
Sponsored (46)
Startups (3893)
State (2)
Stomach cancer (18)
Supply chain (118)
Tariffs (84)
The Weekly (73)
Vaccines (1101)
Venture capital (104)
Weight loss (427)
Women's health (112)
Worklife (19)
Date
Today (121)
Last 7 days (675)
Last 30 days (2799)
Last 365 days (30755)
2026 (8175)
2025 (30966)
2024 (36224)
2023 (41147)
2022 (52410)
2021 (57009)
2020 (55631)
2019 (48419)
2018 (36461)
2017 (33565)
2016 (33156)
2015 (39379)
2014 (32957)
2013 (28010)
2012 (30253)
2011 (30863)
2010 (28832)
Location
Africa (781)
Alabama (93)
Alaska (7)
Arizona (342)
Arkansas (15)
Asia (42218)
Australia (7015)
California (12478)
Canada (3533)
China (1257)
Colorado (533)
Connecticut (535)
Delaware (378)
Europe (92869)
Florida (1861)
Georgia (407)
Hawaii (3)
Idaho (65)
Illinois (987)
India (82)
Indiana (568)
Iowa (23)
Japan (497)
Kansas (133)
Kentucky (47)
Louisiana (40)
Maine (73)
Maryland (1502)
Massachusetts (9018)
Michigan (374)
Minnesota (696)
Mississippi (7)
Missouri (149)
Montana (36)
Nebraska (29)
Nevada (139)
New Hampshire (89)
New Jersey (3326)
New Mexico (30)
New York (3285)
North Carolina (1604)
North Dakota (10)
Northern California (6141)
Ohio (376)
Oklahoma (24)
Oregon (44)
Pennsylvania (2511)
Puerto Rico (27)
Rhode Island (51)
South America (1170)
South Carolina (77)
South Dakota (1)
Southern California (4907)
Tennessee (203)
Texas (1971)
United States (44396)
Utah (376)
Vermont (1)
Virginia (298)
Washington D.C. (81)
Washington State (1010)
West Virginia (4)
Wisconsin (130)
Wyoming (2)
756,029 Results for "ophthalmic technologies inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Apotex Expands Canadian Ophthalmology Portfolio with Health Canada’s Approval of CLOBIVIS™ (Clobetasol Propionate Ophthalmic Suspension, 0.05%)
March 25, 2026
·
1 min read
Press Releases
ZEISS expands ophthalmic workflow portfolio in Canada with enhanced diagnostic, visualization and therapeutic solutions for precision eye care
March 24, 2026
·
8 min read
Press Releases
ZEISS announces NMPA approval in China for powerful ophthalmic microscopes enhancing surgical visualization
February 3, 2026
·
5 min read
Press Releases
TP-03 (lotilaner ophthalmic solution) 0.25% Now Approved in China for the Treatment of Demodex Blepharitis, Triggering a $15M Milestone Payment to Tarsus
March 23, 2026
·
6 min read
Press Releases
Opus Genetics Announces FDA Acceptance of Supplemental New Drug Application for Phentolamine Ophthalmic Solution 0.75% for the Treatment of Presbyopia
February 25, 2026
·
6 min read
Press Releases
Formosa Pharmaceuticals Announces Licensing Agreement with Arrotex, for Commercialization of Clobetasol Propionate Ophthalmic Suspension for the Treatment of Inflammation and Pain Following Ocular Surgery
February 23, 2026
·
4 min read
Press Releases
FDA Accepts Viatris Supplemental New Drug Application for MR-141 (Phentolamine Ophthalmic Solution 0.75%) for the Treatment of Presbyopia
February 25, 2026
·
8 min read
Press Releases
Hubly Surgical awarded Breakthrough Technology Designation for Neurosurgical Products with Premier, Inc.
March 3, 2026
·
2 min read
Press Releases
Quanta System Inc.: Strengthening the U.S. Presence of Italian Laser Technology
March 1, 2026
·
4 min read
Press Releases
LSL PHARMA GROUP SUCCESSFULLY OBTAINED U.S. FDA CERTIFICATION FOR THE MANUFACTURING OF OPHTHALMIC OINTMENTS FOR COMMERCIALIZATION IN THE UNITED STATES
January 29, 2026
·
3 min read
1 of 75,603
Next
